| 翻訳と辞書 |
| The Quality of Life Assessment of Growth Hormone Deficiency in Adults Measure ： ウィキペディア英語版 |
The Quality of Life Assessment of Growth Hormone Deficiency in Adults Measure
The Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) is a disease specific patient-reported outcome measure which measures the effect growth hormone deficiency has on adult patients. The score of the QoL-AGHDA is used to determine the extent to which growth hormone deficiency has affected the patient’s quality of life, and what treatment can then be administered. A high score on the QoL-AGHDA indicates that the patient suffers from many symptoms and therefore has a lower quality of life.
The questionnaire consists of 25 “Yes” or “No” items and is self-administered, meaning that the patient can complete the survey on their own. The QoL-AGHDA addresses seven different areas of concern for growth hormone deficient (GHD) patients. They are: body image and fat distribution, energy level, concentration and memory, irritability and temper, strength and stamina, coping with stress, and physical and mental drive.〔
== History and Language Adaptation ==
The QoL-AGHDA was published in 1999 and was funded by Pharmacia & Upjohn AB, Sweden. The research company that developed the QoL-AGHDA was Galen Research. The measure was originally created for use in UK English, Swedish, Italian, German and Spanish, but later on it was also adapted for the United States, Belgium, the Netherlands, Brazil and Denmark. Subsequent to that, the QoL-AGHDA was translated into Czech, Polish, Serbian and Slovakian.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「The Quality of Life Assessment of Growth Hormone Deficiency in Adults Measure」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|